Biote Reports Third-Quarter 2026 Financial Results
Biote reported financial results for the quarter ended September 30, 2026. The company cited a recent improvement in procedure volume as an early indicator.
Biote (NASDAQ:BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners’ patients, today announced financial results for the third quarter ended September 30, 2026.“While a recent improvement in procedure volume provides early ev…